Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |